Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of microRNA‐22 in regulating neuroinflammation in Alzheimer’s disease
Chenyang Han, Guo Li, Yi Yang, et al.
Brain and Behavior (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Hallie Blevins, Yiming Xu, Savannah Biby, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 270
The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Ya-Shuo Feng, Zixuan Tan, Linyu Wu, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101192-101192
Closed Access | Times Cited: 150
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Tao Liang, Yang Zhang, Suyuan Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases
Delsuz Rezaee, Fatemeh Saadatpour, Nayyereh Akbari, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102090-102090
Closed Access | Times Cited: 44
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 31
ADMSC Exo‐MicroRNA‐22 improve neurological function and neuroinflammation in mice with Alzheimer's disease
Liping Zhai, Heping Shen, Yongjia Sheng, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 15, pp. 7513-7523
Open Access | Times Cited: 71
Pyroptosis, and its Role in Central Nervous System Disease
Yingchao Hu, Bingwei Wang, Sheng Li, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 4, pp. 167379-167379
Closed Access | Times Cited: 66
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
Mohammad Samadian, Mahdi Gholipour, Mohammadreza Hajiesmaeili, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 58
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 55
MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus
Pengcheng Xia, Jing Chen, Yingchao Liu, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 47
Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 12
miRNAs as Therapeutic Tools in Alzheimer’s Disease
Chang Youn Lee, In Soo Ryu, Jin‐Hyeob Ryu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13012-13012
Open Access | Times Cited: 46
Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer’s disease
Li Zeng, Hailun Jiang, Ghulam Md Ashraf, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 256-275
Open Access | Times Cited: 43
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Ya-Shuo Feng, Zixuan Tan, Linyu Wu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111428-111428
Open Access | Times Cited: 42
Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target
Seyed Hamidreza Rastegar-Moghaddam, Alireza Ebrahimzadeh‐Bideskan, Sara Shahba, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 2, pp. 455-467
Closed Access | Times Cited: 38
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
Xian Wu, Teng Wan, Xiaoyu Gao, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 32
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer’s Disease
Jian Shi, Shi‐Wei Huang
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 16-16
Open Access | Times Cited: 20
The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
Wenfang He, Zhiping Hu, Yanjun Zhong, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 5, pp. 2520-2538
Closed Access | Times Cited: 17
MicroRNA-138-5p Regulates Hippocampal Neuroinflammation and Cognitive Impairment by NLRP3/Caspase-1 Signaling Pathway in Rats
Xiaojin Feng, Jialing Hu, Fenfang Zhan, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1125-1143
Open Access | Times Cited: 35
MSC derived EV loaded with miRNA‐22 inhibits the inflammatory response and nerve function recovery after spinal cord injury in rats
Yongjia Sheng, Xiaohong Zhou, Jin Wang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 10268-10278
Open Access | Times Cited: 34
MicroRNA Networks in Cognition and Dementia
Grace S. Blount, Layton Coursey, Jannet Kocerha
Cells (2022) Vol. 11, Iss. 12, pp. 1882-1882
Open Access | Times Cited: 27
MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders
Seyed Hamidreza Rastegar-Moghaddam, Alireza Ebrahimzadeh‐Bideskan, Sara Shahba, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 2694-2701
Closed Access | Times Cited: 26
Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
Yuehua Huang, Xiaoyü Li, Guifei Luo, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top